23andMe requires two-factor authentication to protect user accounts, which provides an additional security layer beyond a password.
This analysis describes what 23andMe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
Given the sensitivity of genetic and health data held in 23andMe accounts, the policy states that two-factor authentication is applied as a baseline security control, which reduces the risk of unauthorized account access.
The updated privacy statement no longer explicitly directs users to a separate Medical Record Privacy Notice for telehealth services or explains that medical information collected through telehealth is governed by different privacy rules. Previously, the policy stated that users choosing telehealth services coordinated through 23andMe would find healthcare privacy protections described in a separate notice. That reference is now absent from the main privacy statement. Users seeking privacy information specific to telehealth services will need to determine independently whether a separate notice exists or contact 23andMe directly using the provided contact information.
View change record →The updated privacy statement no longer explicitly discloses a separate Medical Record Privacy Notice that previously described how medical information is used, disclosed, and maintained for telehealth services. Users who receive telehealth services coordinated through 23andMe may now lack clear notice of which privacy framework governs their medical records, since the reference to that parallel notice has been removed. The organizational scope change from '23andMe Research Institute' to '23andMe' narrows the explicitly named entities responsible for the policy, though operational impact depends on how these entities actually function.
View change record →This new provision highlights security measures as a standalone disclosure, building transparency around account protection mechanisms.
View full change record →The policy states that user accounts are protected with two-factor authentication, meaning access to your genetic data requires both your password and a second verification factor, providing a baseline protection for the sensitive genomic and health information stored in your account.
How other platforms handle this
At Ledger, earning and maintaining our users' trust is a top priority. That's why we are deeply committed not only to protecting your privacy and securing your personal data, but also to being fully transparent about how we handle it.
If you do not have a social security number you may still be eligible to open a limited Revolut personal account. Depending on your immigration status, we may ask you to provide us with a copy of your supported U.S. visa and may limit your access to certain products and features.
After your account is deleted, we keep data about interactions you've had on our service to prevent abuse, ban evaders and others in an effort to protect and ensure the safety and security of our service and our members.
Monitoring
23andMe has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"You create your online account and password. Your account is protected with 2-factor authentication.— Excerpt from 23andMe's 23andMe Privacy Statement
REGULATORY LANDSCAPE: Account security measures for genetic and health data engage FTC standards for reasonable security, GDPR Article 32 security of processing requirements, and California Consumer Privacy Act security obligations. The use of two-factor authentication is consistent with regulatory guidance on appropriate technical safeguards for sensitive personal data. GOVERNANCE EXPOSURE: Low. Disclosure of two-factor authentication as a baseline security control is consistent with reasonable security expectations for a genetic data platform. The governance question is whether 2FA is mandatory or optional for users, which the summary document does not fully clarify. JURISDICTION FLAGS: GDPR and UK GDPR require appropriate technical measures proportionate to the risk; for genetic data, regulatory guidance supports strong authentication controls. California law similarly requires reasonable security. CONTRACT AND VENDOR IMPLICATIONS: No significant contract or vendor implications from this specific disclosure. COMPLIANCE CONSIDERATIONS: Compliance teams should confirm whether two-factor authentication is mandatory for all account types or optional, and whether there are mechanisms to prevent users from disabling it for accounts holding genetic data.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 1 platform + weekly digest. Monitor: 25 platforms + same-day alerts. No credit card required.
Ad personalization controls removed. Contact scanning added. Advertiser data partnerships quietly dropped. A timeline of every change.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
Given the sensitivity of genetic and health data held in 23andMe accounts, the policy states that two-factor authentication is applied as a baseline security control, which reduces the risk of unauthorized account access.
The policy states that user accounts are protected with two-factor authentication, meaning access to your genetic data requires both your password and a second verification factor, providing a baseline protection for the sensitive genomic and health information stored in your account.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by 23andMe.